No. |
Product Name |
CAS No. |
Spec |
Price |
|
| A-1997 |
(R)-6-Hydroxybuspirone HCl(BMS 442608 HCl) ≥99% |
N.A. |
|
|
| A-1998 |
(S)-6-Hydroxybuspirone HCl(BMS 442606 HCl) ≥99% |
N.A. |
|
|
| A-1013 |
(R)-(+)-7-Hydroxy-DPAT HBr((R)-7-OH-DPAT) ≥98% |
1021878-34-1 |
|
|
| A-1016 |
(R)-(+)-8-Hydroxy-DPAT HBr ≥98% |
78095-19-9 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1007 |
(R)-5-Hydroxy-DPAT HBr((R)-5-OH-DPAT) ≥98% |
182210-73-7 |
|
|
| A-1010 |
(R)-6-Hydroxy-DPAT HBr((R)-6-OH-DPAT) ≥98% |
502508-84-1 |
|
|
| A-1014 |
(S)-(-)-7-Hydroxy-DPAT HBr((S)-7-OH-DPAT) ≥98% |
82730-73-2 |
|
|
| A-1017 |
(S)-(-)-8-Hydroxy-DPAT HBr((S)-(-)-8-OH-DPAT) ≥98% |
78095-20-2 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1008 |
(S)-5-Hydroxy-DPAT HBr((S)-5-OH-DPAT) ≥98% |
182210-74-8 |
|
|
| A-1011 |
(S)-6-Hydroxy-DPAT HBr((S)-6-OH-DPAT) ≥98% |
162992-70-3 |
|
|
| A-1006 |
5-Hydroxy-DPAT HBr(5-OH-DPAT) ≥98% |
71787-83-2 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1009 |
6-Hydroxy-DPAT HBr(6-OH-DPAT) ≥99% |
76135-29-0 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1012 |
7-Hydroxy-DPAT HBr(7-OH-DPAT) ≥98% |
76135-30-3 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2168 |
IC 87114 ≥98% |
371242-69-2 |
|
|
| A-1766 |
ICG 001 ≥99% |
847591-62-2 |
|
|
| A-1210 |
ICI 192605 ≥98% |
117621-64-4 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2133 |
iCRT5(CRT Inhibitor iCRT5) ≥99% |
18623-44-4 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1156 |
L-(+)-Ifenprodil tartrate ≥99% |
23210-56-2 (parent) |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1493 |
Iloperidone ≥99% |
133454-47-4 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1394 |
Imatinib Mesylate(CGP 57148B;STI 571;Gleevec) ≥99% |
220127-57-1 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
